Wistar Receives $5.6 Million Grant Renewal from Wellcome Trust to Develop Drug Against Cancers Caused by Epstein-Barr Virus
The Wistar Institute and London-based global charity Wellcome Trust announce that they have signed a follow-on funding agreement in support of ongoing research and development of a new class of drugs useful for treating cancers associated with...
19-May-2015 11:30 AM EDT
The Wistar Institute and Fox Chase Chemical Diversity Center Launch Alliance to Propel Early-Stage Discoveries
Wistar and Fox Chase Chemical Diversity Center advance biomedical science one partnership at a time
5-May-2015 9:05 AM EDT
In recent years, research has shown that cancerous cells have a different metabolism – essential chemical and nutritional changes needed for supporting the unlimited growth observed in cancer– than normal cells. Now, scientists at The Wistar...
28-Apr-2015 12:00 PM EDT
In the last several years, targeted therapies – drugs that directly impact specific genes and proteins involved in the progression of cancer – have been approved for a wide variety of cancers, including melanoma, the deadliest form of skin...
17-Mar-2015 11:00 AM EDT
Philadelphia-based biomedical research institute research The Wistar Institute and Boston-based life sciences company Kerafast, Inc. partner to offer educational opportunities for Wistar postdoctoral fellows and to distribute Wistar reagents through...
16-Mar-2015 3:05 PM EDT
Wistar Receives $1.1M Grant from the Jayne Koskinas Ted Giovanis Foundation for Health and Policy to Establish a Consortium for Breast Cancer Research
The Jayne Koskinas Ted Giovanis (JKTG) Foundation awarded The Wistar Institute a $1.1 million grant to create The Jayne Koskinas Ted Giovanis Breast Cancer Research Consortium at The Wistar Institute. The Consortium will support the highly...
11-Mar-2015 10:00 AM EDT
Researchers in the laboratory of Rugang Zhang have discovered a target for ovarian clear cell carcinoma, a very difficult-to-treat form of the disease.
16-Feb-2015 3:00 PM EST
A study led by researchers at The Wistar Institute has shown that targeting both PI3K and the mitochondria within these cancer cells can dramatically improve the effectiveness of targeted therapy and significantly reduce the chances of developing...
12-Feb-2015 4:00 PM EST
6-Aug-2014 10:00 AM EDT
Dr. Luis Montaner, Wistar Institute HIV/AIDS Expert, Can Address His Work in the Search for a Cure, for World AIDS Day
26-Nov-2013 2:25 PM EST
22-Feb-2013 4:15 PM EST
The Winter Sun May Not Be Warm, but Still Can Be Dangerous. Wistar Melanoma Expert on Wintertime UV Risks
22-Jan-2013 2:30 PM EST